Navigation Links
Artecoll


Artecoll, used in cosmetic plastic surgery as permanent soft tissue filler, is injected under the skin to plump up wrinkles and reduce folds of skin associated with aging such as the nasolabial fold which runs from the corner of the nose to the edges of the mouth. Now produced for Americans in San Diego, California, by Artes Medical, Inc, Artecoll has been used in Europe for many years. It was approved by the U.S. FDA in December, 2006, to treat nasolabial folds with the added condition that a five-year follow up study of patients using Artecoll must be done.

Contents

Composition

Artecoll is mostly collagen, one of the most abundant substances in all mammals. The thinning of collagen in human faces is responsible for aging, wrinkles and lines on the face.[1]

Artecoll consists of 25 percent microscopic Plexiglas plastic beads made of a substance known as polymethylmethacrylate suspended in a solution of 75 percent bovine collagen. The microspheres are 32–40 micrometers in diameter (500 micrometers could fit in the period at the end of this sentence).

Potential risks and side effects

Some researchers have found that large lumps under the skin known as granulomas developed after Artecoll injections. The lumps are a reaction to the injections and can be difficult for doctors to treat.[2]

U.S. Food and Drug Administration approval

Before Artecoll was approved by the U.S. FDA, it was studied in 251 subjects at eight medical centers in the United States. The subjects received Artecoll injections in 1334 wrinkles of the glabella, the heavy wrinkles between the eyebrows, in the corner-of-the-mouth lines, in upper lips and in the nasolabial folds. A similar group of patients received injections of ordinary collagen (with the trade name Zyplast™) in the same places in their faces.

Researchers then studied the patients' improved appearance and the reactions of research subjects to the injections. At the six-month follow up, the researchers found the Artecoll group showed 86.7 percent better augmentation of loose skin than the group which received only collagen. Adverse reactions to collagen and to Artecoll among both groups of patients was reported as about equal.[3]

References

  1. ^ Cohen SR, Homes RE. Artecoll: A long-lasting injectable wrinkle filler material: Report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg. 2004; 114:964-976
  2. ^ Sidwell, R.U.; Mcl Johnson, N; Francis, N. +; Bunker, C.B. Cutaneous sarcoidal granulomas developing after Artecoll® facial cosmetic filler in a patients with newly diagnosed system sarcoidosis. Clinical & Experimental Dermatology, 31(2):208-211. March 2006.
  3. ^ Rullan, Peter Paul M.D. Soft Tissue Augmentation using Artecoll: A Personal Experience. Facial Plastic Surgery. 20(2):111-116, May 2004.

External links


'"/>


(Date:9/22/2014)... Pain does not need to rule your life ... reader-friendly book designed to guide the individual who suffers with ... book is written to help the reader who is struggling ... regain a pain-free life — a daily “go-to” guide on ... pain has become an epidemic, with over 100 million Americans ...
(Date:9/22/2014)... YORK (September 22, 2014) Montefiore Medical Center, Albert Einstein ... Women,s Hospital have received a $300,000 grant from The ... the impact of health Information Technology (IT) on patient ... electronic orders, an important clinical patient safety issue impacted ... will be the first time IT leaders have data ...
(Date:9/22/2014)... Ore. Xanthohumol, a type of flavonoid found in ... study to improve cognitive function in young mice, but ... published in Behavioral Brain Research by scientists ... Medicine at Oregon State University. It,s another step toward ... happens with age in many mammalian species, including humans. ...
(Date:9/22/2014)... Medical experts this past weekend gathered ... discuss brain-related diseases facing an aging population, including ... disorders. , Each of the 50 attendees ... memory care community or hospice office. Silverado, with ... hosts the annual event to facilitate the exchange ...
(Date:9/22/2014)... by University of North Carolina at Chapel Hill researchers ... of people who are experiencing the earliest stages of ... the development of severe mental disorders such as schizophrenia. ... affects about 1 in every 100 people. In severe ... a life compromised, and the burden on family members ...
Breaking Medicine News(10 mins):Health News:Naturopathic Doctor Inspires and Guides Those Who Suffer with Chronic Pain, Pointing the Way Back to Pain-free Living 2Health News:AHRQ grant awarded to study the impact of health IT on patient safety at Montefiore and Einstein and Brigham and Women's Hospital 2Health News:Compound from hops aids cognitive function in young animals 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 3Health News:Blood test may help determine who is at risk for psychosis 2
... but a new study shows that the consequences of occasionally ... according to a new study by University of Alabama at ... the Journal of the American Medical Association . ... the United States, according to the National Survey on Drug ...
... By Serena Gordon HealthDay Reporter , TUESDAY, ... more likely to be hospitalized than their peers who don,t ... finds. What,s more, about two-thirds of the hospitalizations ... illnesses, such as a urinary tract infection, the study shows. ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Jan. 10 ... drinkers -- defined as men who down five or more drinks ... at one time, federal researchers reported Tuesday. Of the 17 ... to 24 years old. But those 65 and older engage in ...
... INDIANAPOLIS -- The School of Science at Indiana University-Purdue ... and Computational Science, an interdisciplinary endeavor dedicated to solving ... environment, and computer science. iM2CS,s parallel mission is to ... scientific issues with which they will be faced. ...
... , TUESDAY, Jan. 10 (HealthDay News) -- Dutch researchers ... the drug Nexavar (sorafenib) in fighting a tough-to-treat form ... experimental drug known as ganetespib showed promise in laboratory ... studies were to be presented Tuesday at an American ...
... Hospital has found that collaborative ,behavioral management may be ... who are paroled. The findings have important implications for ... community correctional population. The study is published in ... print. In the U.S., over 700,000 inmates leave ...
Cached Medicine News:Health News:Marijuana smoke not as damaging to lungs as cigarette smoke 2Health News:Marijuana smoke not as damaging to lungs as cigarette smoke 3Health News:Dementia May Lead to Avoidable Hospitalizations 2Health News:Dementia May Lead to Avoidable Hospitalizations 3Health News:One in Six Americans Binge Drink: CDC 2Health News:One in Six Americans Binge Drink: CDC 3Health News:Revealing causality 2Health News:Mixed News on Tough-to-Treat Lung Cancer 2Health News:Mixed News on Tough-to-Treat Lung Cancer 3Health News:Behavioral management to reduce substance abuse, crime and re-arrest for drug-involved parolees 2Health News:Behavioral management to reduce substance abuse, crime and re-arrest for drug-involved parolees 3
Other medicine definitionOther Tags